TuisONVO • NASDAQ
add
Organovo Holdings Inc
Vorige sluiting
$0,34
Dagwisseling
$0,33 - $0,37
Jaarwisseling
$0,32 - $1,74
Markkapitalisasie
5,56Â m USD
Gemiddelde volume
208,00Â k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 30,00 k | — |
Bedryfskoste | 1,65Â m | -40,54% |
Netto inkomste | -2,55Â m | 36,18% |
Netto winsgrens | -8,50 k | — |
Wins per aandeel | — | — |
EBITDA | -2,54Â m | 37,19% |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 3,17Â m | -58,33% |
Totale bates | 6,75Â m | -39,49% |
Totale aanspreeklikheid | 3,07Â m | 13,64% |
Totale ekwiteit | 3,68 m | — |
Uitstaande aandele | 15,37 m | — |
Prys om te bespreek | 1,43 | — |
Opbrengs op bates | -80,37% | — |
Opbrengs op kapitaal | -101,87% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -2,55Â m | 36,18% |
Kontant van bedrywe | -2,64Â m | 16,10% |
Kontant van beleggings | 0,00 | -100,00% |
Kontant van finansiering | -371,00 k | — |
Netto kontantverandering | -3,01Â m | 3,95% |
Beskikbare kontantvloei | -1,56Â m | 11,89% |
Meer oor
Organovo Holdings, Inc. is an early-stage medical laboratory and research company which designs and develops functional, three dimensional human tissue for medical research and therapeutic applications. Organovo was established in 2007 and is headquartered in San Diego, California. The company uses its internally developed NovoGen MMX Bioprinter for 3D bioprinting. Wikipedia
Gestig
2007
Webwerf
Werknemers
19
